Cell-Based Therapies: Be on the Safe Side

The combination of speed, accuracy and efficiency provided by the Microsart^® ATMP Sterile Release kits means ATMP manufacturers can deliver QC results prior to treatment. In doing so, the industry stands to eliminate one of the outstanding risks to patients posed by ATMP, thereby setting the stage for the use of consistently safe lifesaving cell-based therapies.

Request your free infographic now to learn more about groundbreaking rapid testing technologies driving a new, safer era of ATMP.

Learn more about information-rich solutions for CAR-T research from Sartorius at www.sartorius.com/car-t-research.